Human muscular dystrophy: elevation of urinary dimethylarginines

Area of Science:

• Biochemistry
• Metabolism
• Neuromuscular Diseases

Background:

• Protein methylation is a crucial post-translational modification involved in various cellular processes.
• Dimethylarginines (DMA) and (DM'A) are byproducts of protein methylation and arginine metabolism.
• Alterations in protein methylation have been implicated in various disease states.

Purpose of the Study:

• To investigate urinary excretion levels of NG,NG-dimethylarginine (DMA) and NG,N'G-dimethylarginine (DM'A) in patients with muscular dystrophy.
• To compare these levels with those in healthy individuals and patients with other neuromuscular conditions.
• To explore the potential relationship between protein methylation and the pathogenesis of muscular dystrophy.

Main Methods:

• Urine samples were collected from patients with muscular dystrophy, healthy controls, patients with other neuromuscular diseases, and individuals with disuse muscle atrophy.
• Quantitative analysis of NG,NG-dimethylarginine (DMA) and NG,N'G-dimethylarginine (DM'A) was performed on all urine samples.
• Ratios of DMA to DM'A were calculated for each group.

Main Results:

• Patients with muscular dystrophy exhibited significantly higher urinary concentrations of DMA compared to all other groups.
• The urine of muscular dystrophy patients showed elevated ratios of DMA to DM'A.
• No significant differences in DMA or DM'A excretion were observed in patients with other neuromuscular diseases or disuse muscle atrophy compared to controls.

Conclusions:

• Elevated urinary DMA and high DMA to DM'A ratios are potential biomarkers for muscular dystrophy.
• The findings suggest a dysregulation of protein methylation processes in muscular dystrophy.
• Further research is warranted to elucidate the precise role of protein methylation in muscular dystrophy progression.